Analyze Diet
Applied microbiology1973; 26(4); 566-569; doi: 10.1128/am.26.4.566-569.1973

Equine abortion (herpes) virus: evaluation of markers in a field vaccination trial.

Abstract: Twelve mares were vaccinated with attenuated equine abortion virus (EAV) strain RAC-H. Two nonvaccinated mares served as controls. In at least three mares the vaccination appeared to coincide with a natural infection. This was indicated by characterization of the EAV isolated from nasal secretions of six vaccinated mares, a nonvaccinated control, and also from the lung, spleen, and liver of a fetus aborted by a vaccinated mare. The relative sensitivity of the isolated EAV to dithiothreitol was used to distinguish the RAC-H strain and wild-type virus. Of the 10 EAV isolates, four were recognized as being the vaccine strain while six were recognized as being wild-type strains. Three of the latter originated from two vaccinated mares and a nonvaccinated control, and three were recovered from the fetus. The ability of the EAV strains to form plaques in a cloned line of L cells proved to be unsuitable for use as a marker in this study.
Publication Date: 1973-10-01 PubMed ID: 4796167PubMed Central: PMC379849DOI: 10.1128/am.26.4.566-569.1973Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study investigates the effectiveness of a vaccine for equine abortion virus (EAV), finding that three vaccinated mares may have had a natural infection concurrent with vaccination. The research also explores strains of the virus found in vaccinated and non-vaccinated mares, as well as in a fetus, while attempting to distinguish between the vaccine strain and wild-type strains.

Study Set-Up

  • The research involved twelve mares which were given a vaccine derived from an attenuated (weakened) EAV strain labelled RAC-H. Two mares that did not receive the vaccination were used as control subjects for comparison.
  • The scientists suspected that a natural infection was present in at least three of the vaccinated mares, possibly happening around the time of vaccination.

Virus Isolation and Characterization

  • Part of the research included isolating and characterizing the EAV from nasal secretions of six vaccinated mares, one non-vaccinated mare, and from various organs of a fetus aborted by a vaccinated mare.
  • The scientists made distinctions between the RAC-H strain (used in the vaccine) and the wild-type virus by assessing how sensitive isolated EAV was to a chemical named dithiothreitol.

Findings

  • Among the ten EAV isolates, the scientists determined four to be the vaccine strain, while the remaining six were identified as wild-type strains.
  • Three of the wild-type strains came from two vaccinated mares and a non-vaccinated control, while the other three were obtained from the aborted fetus.

L Cell Plaque Formation

  • The research paper also mentioned an attempt to use the ability of the EAV strains to form plaques (visible patches of viral infection) in a cloned line of “L cells” (a type of laboratory cell culture) as a marker for the study.
  • However, this method was deemed unsuitable for use in this research.

Overall, the study indicates that natural infection may influence the effectiveness of the EAV vaccine, and further research is needed to understand these interactions and to develop more reliable markers for study.

Cite This Article

APA
Klingeborn B. (1973). Equine abortion (herpes) virus: evaluation of markers in a field vaccination trial. Appl Microbiol, 26(4), 566-569. https://doi.org/10.1128/am.26.4.566-569.1973

Publication

ISSN: 0003-6919
NlmUniqueID: 7605802
Country: United States
Language: English
Volume: 26
Issue: 4
Pages: 566-569

Researcher Affiliations

Klingeborn, B

    MeSH Terms

    • Abortion, Veterinary / microbiology
    • Animals
    • Antibodies, Viral / biosynthesis
    • Cells, Cultured
    • Dithiothreitol / pharmacology
    • Female
    • Herpesviridae / drug effects
    • Herpesviridae / immunology
    • Horse Diseases / prevention & control
    • Horses
    • Neutralization Tests
    • Pregnancy
    • Rabbits / immunology
    • Vaccination
    • Viral Plaque Assay

    References

    This article includes 8 references
    1. Mayr A, Pette J, Petzoldt K, Wagener K. [Studies on the development of a live vaccine against rhinopneumonitis (mare abortion) of horses].. Zentralbl Veterinarmed B 1968 Apr;15(3):406-18.
      pubmed: 5692868
    2. Bryans JT. On immunity to disease caused by equine herpesvirus 1.. J Am Vet Med Assoc 1969 Jul 15;155(2):294-300.
      pubmed: 4307796
    3. Borgen HC. Differentiation of equine herpesvirus type I strains by a plaque marker. Brief report.. Arch Gesamte Virusforsch 1970;32(2):283-5.
      pubmed: 5533700doi: 10.1007/BF01249964google scholar: lookup
    4. Borgen HC. Equine herpesvirus type 1: the L- character in two of forty-three field isolates. Brief report.. Arch Gesamte Virusforsch 1972;36(3):391-3.
      pubmed: 5063121doi: 10.1007/BF01249870google scholar: lookup
    5. Klingeborn B, Dinter Z. Equine abortion (herpes) virus: strain differences in susceptibility to inactivation by dithiothreitol.. Appl Microbiol 1972 Jun;23(6):1121-4.
      pubmed: 4339509doi: 10.1128/am.23.6.1121-1124.1972google scholar: lookup
    6. DOLL ER, BRYANS JT. Incubation periods for abortion in equine viral rhinopneumonitis.. J Am Vet Med Assoc 1962 Aug 1;140:351-4.
      pubmed: 13887042
    7. DOLL ER. Immunization against viral rhinopneumonitis of horses with live virus propagated in hamsters.. J Am Vet Med Assoc 1961 Dec 15;139:1324-30.
      pubmed: 13887043
    8. DIDERHOLM H, STENKVIST B, PONTEN J, WESSLEN T. TRANSFORMATION OF BOVINE CELLS IN VITRO AFTER INOCULATION OF SIMIAN VIRUS 40 OR ITS NUCLEIC ACID.. Exp Cell Res 1965 Feb;37:452-9.
      pubmed: 14298956doi: 10.1016/0014-4827(65)90192-8google scholar: lookup

    Citations

    This article has been cited 0 times.